Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Tonon

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Cancer Discovery|January 12, 2024
UNCAN.eu: Toward a European Federated Cancer Research Data HubMichael Boutros, Michael Baumann, Anna Bigas, et al.
Dalton Transactions (Cambridge, England : 2003)|February 19, 2025
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapyThomas Scattolin, Enrico Cavarzerani, Dario Alessi, et al.
Cancer Research|September 23, 2020
FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and AutophagyNicola Manfrini, Marilena Mancino, Annarita Miluzio, et al.
RSC Advances|May 2, 2025
Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexesTommaso Lorenzon, Maria Vescovo, Michele Maiullari, et al.
The Journal of Clinical Investigation|November 10, 2015
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancerBeatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
Cancer Research|June 23, 2023
Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal AdenocarcinomaGiuseppina Arbore, Luca Albarello, Gabriele Bucci, et al.
Blood|January 31, 2016
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironmentRoberta Valsecchi, Nadia Coltella, Daniela Belloni, et al.
Cancer Research|February 13, 2016
Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma PatientsMimma Bianco, Anna Maria Gasparri, Barbara Colombo, et al.
Translational Andrology and Urology|March 21, 2025
DNA methylation alterations in prostate cancer: from diagnosis to treatmentFrancesco Barletta, Marco Bandini, Giuseppe Ottone Cirulli, et al.
Blood|February 7, 2009
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cellsYu-Tzu Tai, Ender Soydan, Weihua Song, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Cancer Discovery|January 12, 2024
UNCAN.eu: Toward a European Federated Cancer Research Data HubMichael Boutros, Michael Baumann, Anna Bigas, et al.
Dalton Transactions (Cambridge, England : 2003)|February 19, 2025
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapyThomas Scattolin, Enrico Cavarzerani, Dario Alessi, et al.
Cancer Research|September 23, 2020
FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and AutophagyNicola Manfrini, Marilena Mancino, Annarita Miluzio, et al.
RSC Advances|May 2, 2025
Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexesTommaso Lorenzon, Maria Vescovo, Michele Maiullari, et al.
The Journal of Clinical Investigation|November 10, 2015
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancerBeatrice Rondinelli, Dalia Rosano, Elena Antonini, et al.
Cancer Research|June 23, 2023
Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal AdenocarcinomaGiuseppina Arbore, Luca Albarello, Gabriele Bucci, et al.
Blood|January 31, 2016
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironmentRoberta Valsecchi, Nadia Coltella, Daniela Belloni, et al.
Cancer Research|February 13, 2016
Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma PatientsMimma Bianco, Anna Maria Gasparri, Barbara Colombo, et al.
Translational Andrology and Urology|March 21, 2025
DNA methylation alterations in prostate cancer: from diagnosis to treatmentFrancesco Barletta, Marco Bandini, Giuseppe Ottone Cirulli, et al.
Blood|February 7, 2009
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cellsYu-Tzu Tai, Ender Soydan, Weihua Song, et al.
Pageof 13